- During its analyst briefing held on 1 Dec 23, IHH Healthcare (SGX:Q0F) identified 5 pillars of growth to support continued revenue growth, and targets double-digit ROE ahead. They include:
- organic bed expansion,
- - Read this at SGinvestors.io -
- developing new growth engines,
- accretive M&A and
- turnaround of underperforming assets.
Room for EBITDA expansion with strong underlying demand
- In Malaysia, bed occupancy rate (BOR) improved to 74% in 3Q23, the highest in the past year, with growth in both local and foreign patients. IHH Healthcare sees room for improvement from the addition of new beds across the country.
- India’s EBITDA margin rose to a historical high of 21.8% in 3Q23, with scope to grow given IHH Healthcare’s ongoing portfolio evaluation of its hospitals.
- - Read this at SGinvestors.io -
- In Hong Kong, 3Q23 operations were affected by the typhoon in Sep, resulting in only modest revenue growth of 0.6%, but IHH Healthcare has ramped up opex ahead of new bed openings, resulting in EBITDA decline of 30.2% q-o-q.
Expanding across the healthcare continuum in Singapore & Hong Kong
- Read more at SGinvestors.io.
